Tweedy, Browne Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7M Sell
59,279
-870
-1% -$215K 1.12% 18
2026
Q2
$14.5M Sell
60,149
-60
-0.1% -$13.1K 1.1% 20
2026
Q1
$11.4M Buy
+60,209
New +$10.5M 0.9% 21

Other funds holding JAZZ

Tweedy, Browne Co's JAZZ Position: Q3 2026 in Review

Tweedy, Browne Co reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.4% in Q3 2026, selling an estimated $215K and leaving 59,279 shares worth $13.7M. The position accounts for 1.12% of the portfolio, ranked #18.

Tweedy, Browne Co first reported a position in JAZZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $14.5M in Q2 2026. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Tweedy, Browne Co held 59,279 shares of Jazz Pharmaceuticals worth $13.7M as of Q3 2026.
  • Tweedy, Browne Co sold 870 Jazz Pharmaceuticals shares in Q3 2026, an estimated $215K.
  • Jazz Pharmaceuticals made up 1.12% of Tweedy, Browne Co's portfolio in Q3 2026, its #18 holding.
  • Tweedy, Browne Co first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Tweedy, Browne Co's Jazz Pharmaceuticals position peaked at $14.5M in Q2 2026.
  • 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Tweedy, Browne Co's 13F filing for Q3 2026, filed 4 Nov 2026.